RxDoctor Payments Data

Benjamin Kamel, DPM

Foot & Ankle Surgery · Pomona, CANPI 1396192712

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,000 of the $36,199 with a category attached, or 60.8%. Arthrex accounts for 81.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $10,888 and has fallen 76.4% since, to $2,566 in 2025. Among foot & ankle surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,199in general payments, 2019–2025

Across 83 payments — averaging $436.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$30K
  • Empire Medical, Inc$3K
  • Medshape, Inc.$2K
  • Butterfly Network, Inc.$720
  • Stryker$575
  • Smith+Nephew$308
  • plus $382 from 9 others

What the payments were for

  • Consulting fees$2,8198%
  • Speaking & faculty fees$22,00061%
  • Travel & lodging$1,7255%
  • Food & beverage$2,4557%
  • Education$7,20020%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,199 in reported general payments places this provider in the 95th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$799,538
Medicare patients
445
Services billed
2,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen64$831
Ibuprofen93$537
Ondansetron Hcl61$325
Terbinafine Hcl12$249
Gabapentin32$193
Cephalexin12$60
Tramadol Hcl22$55
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$24

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Pomona

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →